Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-06-16 @ 4:07 PM
Study NCT ID:
NCT03801902
Status:
COMPLETED
Last Update Posted:
2025-09-23
First Post:
2019-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial
Sponsor:
Organization: